deltatrials
Terminated NA NCT00574756

Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction

The Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction

Sponsor: University of California, San Diego

Conditions Diastolic Heart Failure Echocardiography Ranolazine Tissue Doppler Ultrasound
Interventions ranolazine
Updated 5 times since 2017 Last updated: Jul 31, 2019 Started: Dec 31, 2007 Primary completion: Mar 31, 2010 Completion: Mar 31, 2010

A NA clinical study on Diastolic Heart Failure and Echocardiography, this trial is terminated or withdrawn. The trial is conducted by University of California, San Diego and has accumulated 5 data snapshots since 2007. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated NA

  4. Sep 2019 — Jan 2021 [monthly]

    Terminated NA

    Status: Unknown Status → Terminated

  5. Jan 2017 — Sep 2019 [monthly]

    Unknown Status NA

    First recorded

Dec 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of California, San Diego
Data source: University of California, San Diego

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • San Diego, United States